Collectively, our data indicate that there was a redistribution of cytochrome c and activations of caspase-9 and caspase-3 in response to the pro-apoptotic effect of tigecycline in the CML cell lines. Here, CYCS is linked to chronic myelogenous leukemia, BCR-ABL1 positive.